Effects of hormone replacement therapy on serum lipids in elderly women: A randomized, placebo-controlled trial

Annals of Internal Medicine

Volumn 134, Issue 9 I, 2001, Pages 754-760

  Binder, E F ^a   Williams, D B ^a   Schechtman, K B ^a   Jeffe, D B ^a   Kohrt, W M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEDROXYPROGESTERONE ACETATE; PLACEBO;

AGED; ARTICLE; BODY FAT; BODY WEIGHT; BREAST DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ELDERLY CARE; FEMALE; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; HUMAN TISSUE; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; VAGINA BLEEDING;

EID: 0035340627     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-134-9_part_1-200105010-00012     Document Type: Article

References (23)

1. Coronary risk factors and their modification: Lipids, smoking, hypertension, estrogen, and the elderly
2. Update on hyperlipidemia in the elderly: Is this a risk factor for heart disease?
3. Cholesterol and coronary heart disease. The importance of patient-specific attributable risk
4. HDL cholesterol predicts coronary heart disease mortality in older persons
5. Cardiovascular mortality and noncontraceptive use of estrogen in women: Results from the lipid research clinics program follow-up study
6. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study
7. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease
8. Peak aerobic power is an important component of physical performance in older women
9. Exercise
10. Effects of endurance exercise and hormone replacement therapy on serum lipids in older women
11. Cyclic hormone replacement therapy using quarterly progestin
12. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women
13. Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women
14. Drug related negative side-effects is a common reason for poor compliance in hormone replacement therapy
15. Symptom relief and side effects of postmenopausal hormones: Results from the postmenopausal estrogen/progestin interventions trial
16. The effect of low-dose continuous estrogen and progesterone therapy with calcium and vitamin D on bone in elderly women. A randomized, controlled trial
17. Lack of association between cholesterol and coronary heart disease mortality and morbidity, and all-cause mortality in persons older than 70 years
18. Total serum cholesterol levels and mortality risk as a function of age. A report based on the Framingham data
19. Plasma lipids and lipoproteins and the incidence of cardiovascular disease in the very elderly. The bronx aging study
20. Serum lipids and incidence of coronary heart disease
21. Cholesterol and heart disease in older persons and women. Review of an NHLBI workshop